is a resource that provides valuable information
on PPH and the recall
of fen phen.
Fen-phen is the common name for the combination of the drugs
pondimin (fenfluramine), redux (dexfenfluramine) and phentermine.
Several years ago, the diet industry widely marketed the drug
as a "miracle cure" for weight loss. In July of
1997, the FDA requested that the drug, and dangerous
derivations of fen-phen, be recalled from the market.
Although fenfluramine and dexfenfluramine are no longer marketed
in the U.S., individuals that took fen-phen may just now be
experiencing medical conditions associated with the drug,
including a serious and potentially fatal condition call primary
Since the fen
phen recall numerous individual and class action lawsuits
began to be filed throughout the entire country due to the
deaths and serious
cardiovascular conditions that were the direct result
of fen phen use. Evidence that fen phen manufacturer, American
Home Products, was aware of the potential fen phen risks well
before the recall began to surface. By the time fen phen was
pulled off the shelves an estimated 6 million to 7 million
people in the U.S. had taken the diet drug.
As of January 3, 2002 the Nationwide
Class Action Settlement Agreement with American Home Products
Corporation received Final Judicial Approval, allowing anyone
who has sustained injuries and health complications from fen
phen to collect their claims.
For more information regarding PPH lawsuits, please contact
Fen Phen and PPH Information
Dr. Michael Weintraub developed fen phen while
working as a researcher at the University of Rochester for
the short-term management of obesity.
the full story . . .